
Nexus Spine Appoints David Ivanko as Vice President of Quality Engineering and Manufacturing and Andrew Shepherd as Vice President of Marketing
January 11, 2022
Nexus Spine announced key appointments to its leadership team that includes David Ivanko as Vice President of Quality Engineering and Manufacturing and Andrew Shepherd as Vice President of Marketing. The additions are part of a recently initiated strategy to move the company from a proof-of-concept phase to rapid commercialization of its novel compliant mechanism-based systems, consisting of PressON™ fixation, Tranquil™ interbody fusion, and upcoming technologies currently in development.
Mr. Ivanko brings more than 25 years of Quality and Manufacturing Engineering experience in the medical device industry to the organization. Prior to Nexus, he most notably served as Vice President of Quality Engineering for NuVasive, Inc. where he was responsible for all aspects of product quality from development to production to distribution.
Mr. Shepherd is also a highly accomplished veteran of the spinal implant industry that includes a lengthy career with Titan Spine where he served as Vice President of Marketing and was instrumental in establishing the surface technology segment in spine.
“I have long admired the quality of NuVasive products and instrumentation as well as the unique marketing approach of Titan Spine,” commented David Hawkes, President of Nexus Spine. “So, it made sense to me to pursue the two individuals responsible for those functions and combine their expertise with the technological capabilities and product portfolio of Nexus. I am very pleased to welcome Dave and Andrew to our leadership team as we begin to execute our comprehensive strategy to accelerate sales of our groundbreaking compliant mechanism-based systems.”
Read the original article here »
Contact:
Andrew Shepherd
andrew.shepherd@nexusortho.com
Recent News
- Co-Diagnostics Announces First Full Vector Smart® Laboratory Installation for Native American Tribe
- Co-Diagnostics to Showcase Co-Dx PCR Platform* and MTB Test at WHX Labs Johannesburg, Highlight Ebola Assay Development
- Co-Diagnostics Highlights Vector Smart® Momentum Following New Federal Initiative on Vector-Borne Disease
- BlueWind Medical Announces Humana Coverage of Revi® for Urgency Urinary Incontinence, Expanding Access to Millions of Patients
- Myriad Genetics and SOPHiA GENETICS Announce New Collaboration to Advance Prostate Genomic Instability Score Technology
- BD and U.S. Government Launch Landmark Partnership to Expand U.S. Manufacturing and Strengthen America’s Healthcare Resilience














